Claims for Patent: 10,526,594

Summary for Patent: 10,526,594

Title:	Recombinantly produced neutral protease originating from Paenibacillus polymyxa
Abstract:	The present disclosure provides the sequence of a Paenibacillus polymyxa preproenzyme which is the precursor of a neutral protease, expression thereof in a transformed host organism, and methods for production of the neutral protease, by recombinant means. Further, use of the recombinantly produced neutral protease is disclosed in the field of cell biology, particularly for the purpose of tissue dissociation. The disclosure also includes blends with other proteases. Further disclosed are nucleotide sequences encoding the neutral protease.
Inventor(s):	Greiner-Stoeffele; Thomas (Soemmerda, DE), Schoenert; Stefan (Leipzig, DE)
Assignee:	Roche Diagnostics Operations, Inc. (Indianapolis, IN)
Application Number:	15/334,658
Patent Claims:	1. A method for making a blend of a plurality of proteases, comprising the steps of (a) transforming a host organism with an expression vector comprising a nucleic acid sequence encoding a neutral protease comprising the amino acid sequence of SEQ ID NO: 5, thereby obtaining a transformed host organism, wherein the host organism is a gram-positive prokaryotic species; (b) culturing the transformed host organism in a culture medium, wherein the transformed host organism secretes the neutral protease into the culture medium; (c) isolating the secreted neutral protease; and (d) mixing the isolated neutral protease provided in step (c) with an additional protease; thereby making a blend of a plurality of proteases. 2. The method according to claim 1, wherein the additional protease is selected from the group consisting of a collagenase and a thermolysin. 3. A method for recombinantly producing a neutral protease, the method comprising the steps of (a) providing an expression vector comprising a DNA with a nucleotide sequence encoding a neutral protease comprising the amino acid sequence of SEQ ID NO: 5; (b) transforming a host organism of the species Bacillus amyloliquefaciens with the expression vector, thereby obtaining a transformed host organism; (c) culturing the transformed host organism in a culture medium, wherein the transformed host organism secretes the neutral protease into the culture medium; and (d) isolating the secreted neutral protease; thereby recombinantly producing the neutral protease. 4. The method according to claim 3, wherein the nucleotide sequence of the DNA comprises the sequence of position 34 to position 1896 of SEQ ID NO: 6. 5. The method according to claim 3, wherein the culture medium is a liquid medium. 6. The method according to claim 5, wherein step (d) comprises isolating the secreted neutral protease from the liquid medium. 7. The method according to claim 3, wherein the host organism is deficient of an extracellular protease selected from Npr and Apr.

Details for Patent 10,526,594

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2032-07-09